JP Morgan Maintains Underweight on Moderna, Raises Price Target to $102

Benzinga · 1d ago
JP Morgan analyst Jessica Fye maintains Moderna (NASDAQ:MRNA) with a Underweight and raises the price target from $77 to $102.